Techniques in Regional Anesthesia & Pain Management
Volume 14, Issue 2 , Pages 86-98, April 2010

European perspectives on upcoming analgesics: What do they have that we don't—and what do they think about them?

  • Bart Morlion, MD

      Affiliations

    • Leuven Center for Algology and Pain Management, University Hospitals, Leuven, Belgium
  • ,
  • Joseph V. Pergolizzi Jr, MD

      Affiliations

    • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland and Department of Anesthesiology, Georgetown University School of Medicine, Washington, District of Columbia
    • Corresponding Author InformationAddress reprint requests and correspondence: Joseph V. Pergolizzi Jr, MD, 840 111th Avenue North, Suite 7, Naples, FL 34108
  • ,
  • Robert B. Raffa, PhD

      Affiliations

    • Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania

Regulatory climate, medical culture, and history have created geographic distinctions in analgesics. In particular, Europe has experience with many commercially available analgesics that have recently been introduced or may soon be introduced to the USA market. The authors selected 4 analgesics widely used in Europe that may be less familiar to American clinicians: transdermal buprenorphine, essential oxygen oil, tapentadol ER, and intravenous diclofenac. These agents are far from the only such agents worthy of consideration but were selected as they range from a new formulation for a familiar drug, an over-the-counter topical product, an oral opioid, and a very popular nonsteroidal anti-inflammatory agent. The clinical studies performed on these agents can help inform physician prescribing choices, when these drugs are available in the USA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1084-208X(10)00019-4

doi:10.1053/j.trap.2010.03.002

Refers to erratum:

  • Erratum: European perspectives on upcoming analgesics

    Techniques in Regional Anesthesia & Pain Management July 2010 (Vol. 14, Issue 3, Page 142)

Techniques in Regional Anesthesia & Pain Management
Volume 14, Issue 2 , Pages 86-98, April 2010